50.84 USD
--0.57
1.11%
At close Updated Oct 28, 2:42 PM EDT
1 day
-1.11%
5 days
1.74%
1 month
11.37%
3 months
2.75%
6 months
-3.64%
Year to date
5.5%
1 year
-6.48%
5 years
10.19%
10 years
-1.26%
 

About: Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Employees: 82,878

0
Funds holding %
of 7,500 funds
0
Analysts bullish %
of 1 analysts
0
Positive news %
of 26 articles
Price charts implemented using Lightweight Charts™